P3.02b-102 Osimertinib Benefit in ctDNA T790M Positive, EGFR-Mutant NSCLC Patients

Subjects

Subjects :

0301 basic medicine
Pulmonary and Respiratory Medicine
business.industry
Mutant
03 medical and health sciences
T790M
030104 developmental biology
0302 clinical medicine
Oncology
030220 oncology & carcinogenesis
Cancer research
Medicine
Osimertinib
business

Details

ISSN :

15560864

Volume :

12

Database :

OpenAIRE

Journal :

Journal of Thoracic Oncology

Accession number :

edsair.doi...........b8f38886a8aa31d6601b9d9fd6b5467b

Full Text :

https://doi.org/10.1016/j.jtho.2016.11.1770